Categories: DiagnosticsDNANews

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

SALT LAKE CITY, Oct. 30, 2025 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will host a virtual fireside chat on Wednesday, November 5, 2025 at 11:00 am ET.

Join Dwight Egan, CEO of Co-Dx, for an update on the Company’s growth initiatives, including its recently announced definitive agreement with Arabian Eagle in the Kingdom of Saudi Arabia to form CoMira Diagnostics and to advance the regional deployment of the Co-Dx™ PCR platform* across the Middle East.

Virtual Fireside Chat Details

A Q&A session will take place at the end of the discussion, and a recording of the fireside chat will be available on Co-Dx’s Investor Relations website following the event. To ensure your questions are addressed, please submit them in advance to CODX@kcsa.com.

*The Co-Dx PCR platform (including the PCR Home™, PCR Pro™, mobile app, and all associated tests) is subject to review by the FDA and/or other regulatory bodies and is not currently available for sale.

About Co-Diagnostics, Inc.:

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company’s technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to regulatory review and not currently for sale) and to identify genetic markers for use in applications other than infectious disease.

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-to-host-fireside-chat-on-november-5th-with-ceo-dwight-egan-to-discuss-recently-announced-definitive-agreement-in-saudi-arabia-302600199.html

SOURCE Co-Diagnostics

Staff

Recent Posts

This World Cancer Day, St. Baldrick’s Foundation Leads the Charge Against Childhood Cancer

Los Angeles, California--(Newsfile Corp. - February 4, 2026) - This World Cancer Day, the St.…

2 hours ago

The Leadership Shift Powering Doceree’s Next Chapter in the US: Kamya Elawadhi Announced as Co-Founder & President

Strategic elevation signals bold expansion as Doceree redefines healthcare marketing with AI-powered precision and purposeSHORT…

4 hours ago

Canvas Medical Named 2026 Best in KLAS for Ambulatory Specialty EHR

Next-generation EMR platform recognized for helping specialty practices deliver efficient, personalized patient careSAN FRANCISCO, Feb.…

4 hours ago

Kontakt.io Introduces Supply Chain AI to Transform Care Support Operations

Agentic AI integrates EHR and RTLS data to automate equipment workflows and improve operational efficiency,…

4 hours ago

Robotic Surgery Market Is No Longer a Technology Story. It Is a Discipline Test for Hospitals: MMR Statistics

PUNE, India, Feb. 4, 2026 /PRNewswire/ -- For nearly a decade, robotic surgery was sold as progress.…

4 hours ago

Champion Insights Officially Opens Enrollment to Investigate ALS Risk in High-Performance Athletes, Military Members, and First Responders

Ambitious nationwide study will enroll 500 participants to examine genetic, biological, and environmental factors linked…

4 hours ago